Literaturverzeichnis

1. Almawi WY, Abou Jaoude MM, Li XC. Transcriptional and post-transcriptional mechanisms of glucocorticoid antiproliferative effects. Hematol Oncol 2002; 20: 17-32

2. Amersi F, Buelow R, Kato H, Ke B, Coito AJ, Shen X, Zhao D, Zaky J, Melinek J, Lassman CR, Kolls JK, Alam J, Ritter T, Volk HD, Farmer DG, Ghobrial RM, Busuttil RW, Kupiec-Weglinski JW. Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J Clin Invest 1999; 104: 1631-1639

3. Amsterdam A, Tajima K, Sasson R. Cell-specific regulation of apoptosis by glucocorticoids: implication to their anti-inflammatory action. Biochem Pharmacol 2002; 64: 843-850

4. Arai M, Thurman RG, Lemasters JJ. Contribution of adenosine A(2) receptors and cyclic adenosine monophosphate to protective ischemic preconditioning of sinusoidal endothelial cells against Storage/Reperfusion injury in rat livers. Hepatology 2000; 32: 297-302

5. Arai M, Thurman RG, Lemasters JJ. Ischemic preconditioning of rat livers against cold storage-reperfusion injury: role of nonparenchymal cells and the phenomenon of heterologous preconditioning. Liver Transp 2001; 7: 292-299

6. Arii S, Teramoto K, Kawamura T. Current progress in the understanding of and therapeutic strategies for ischemia and reperfusion injury of the liver. J Hepatobiliary Pancreat Surg 2003; 10: 189-194

7. Azzarone A, Francavilla A, Carrieri G, Gasbarrini A, Scotti-Foglieni C, Fagiuoli S, Cillo U, Zeng QH, Starzl TE. Effects of in vivo and in vitro hepatocyte proliferation of methylprednisolone, azathioprine, mycophenolate acid, mizoribine, and prostaglandine E1. Transplant Proc 1992; 2868-2871

8. Barnes PJ. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clinical Science 1998; 94: 557-572

9. Belghiti J, Noun R, Malafosse R, Jagot P, Sauvanet A, Pierangeli F, Marty J, Farges O. Continuous versus intermittent portal triad clamping for liver resection. A controlled study. Ann Surg 1999; 3: 369-375

10. Bilbao G, Contreras JL, Eckhoff DE, Mikheeva G, Krasnykh V, Douglas JT, Thomas FT, Thomas JM, Curiel DT. Reduction of ischemia-reperfusion injury of the liver by in vivo adenovirus-mediated gene transfer of the antiapoptotic Bcl-2 gene. Ann Surg 1999; 230: 185-193

11. Bilzer M, Paumgartner G, Gerbes AL. Glutathione protects the rat liver against reperfusion injury after hypothermic preservation. Gastroenterology 1999; 117: 200-210

12. Bilzer M, Gerbes AL. Preservation injury of the liver: mechanisms and novel therapeutic strategies. J Hepatol 2000; 32: 508-515

13. Bismuth H, Castaing D, Garden J. Major hepatic resection under total vascular exclusion. Ann Surg 1989; 210: 13-19

14. Blumhardt G, Ringe B, Bechstein WO, Pichlmayr R. Current clinical management of organoprotection in hepatic surgery. Klin Wochenschr 1986 (Suppl VII): 144-145

15. Camargo CA, Madden JF, Gao W, Selvan RS, Clavien PA. Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology 1997; 26: 1513-1520

16. Carini R, De Cesaris MG, Splendore R, Vay D, Domenicotti C, Nitti MP, Paola D, Pronzato MA, Albano E. Signal pathway involved in the development of hypoxic preconditioning in rat hepatocytes. Hepatology 2001; 33: 131-139

17. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159

18. Clavien PA, Harvey PRC, Strasberg SM. Preservation and reperfusion injuries in liver allografts: Overview and synthesis of current studies. Transplantation 1992; 53: 957-978

19. Clavien PA. Sinusoidal endothelial cell injury during hepatic preservation and reperfusion. Hepatology 1998; 28: 281-285

20. Clavien PA, Yadav S, Sindram D, Bentley RC. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg 2000; 232: 155-162

21. Clavien PA, Selzner M, Rudiger HA, et al. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg 2003; 238: 843-850

22. Colletti LM, Kunkel SL, Green M, Burdick M, Strieter RM.Shock. Hepatic inflammation following 70% hepatectomy may be related to up-regulation of epithelial neutrophil activating protein-78. Shock 1996; 6: 403-404

23. Costas MA, Muller Igaz L, Holsboer F, Arzt E. Transrepression of NF-kappaB is not required for glucocorticoid-mediated protection of TNF-alpha-induced apoptosis on fibroblasts Biochim Biophys Acta 2000; 1499: 122-129

24. Court FG, Wemyss-Holden SA, Dennison AR, Maddern GJ. The mystery of liver regeneration. Br J Surg 2002; 89: 1089-1095

25. Ezaki T, Koyanagi N, Toyomasu T, Ikeda Y, Sugimachi K. Natural history of hepatectomy regarding liver function: a study of both normal livers and livers with chronic hepatitis and cirrhosis. Hepatogastroeneterol 1998; 45: 1795-1801

26. Downey JM, Liu GS, Thornton JD. Adenosine and the anti-infarct effects of preconditioning. Cardiovasc Res 1993; 27: 3-8

27. Downey JM, Cohen MV, Ytrehus K, Liu Y. Cellular mechanisms in ischemic preconditioning: the role of adenosine and protein kinase C. Ann NY Acad Sci 1994; 723: 82-98

28. Evans-Storms RB, Cidlowski JA. Delineation of an antiapoptotic action of glucocorticoids in hepatoma cells: the role of nuclear factor-kappaB. Endocrinology 2000; 141: 1854-1862

29. Fausto N, Laird AD, Webber EM. Role of growth factors and cytokines in hepatic regeneration. FASEB J 1995; 9: 1527-1536

30. Fausto N. Liver regeneration. J Hepatol 2000; 32 (S1): 19-31

31. Fausto N. Liver regeneration: From laboratory to clinic. Liver Transplant 2001; 10: 835-844

32. Figueroa I, Santiago-Delpin EA. Steroid protection of the liver during experimental ischemia. Surg Gynecol Obstet 1975; 140: 368-370

33. Fornander J, Hellman A, Hasselgren PO. Effects of methylprednisolone on protein synthesis and blood flow in the postischemic liver. Circ Shock 1984; 12: 287-295

34. Fujioka T, Murakami M, Niiya T, Aoki T, Murai N, Enami Y, Kusano M. Effect of methylprednisolone on the kinetics of cytokines and liver function of regenerating liver in rats. Hepatology Research 2001; 19: 60-73

35. Furchgott RF, Zawadski JV. The obligatory role of the endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-376

36. Gerlach C, Sakkab DY, Scholzen T, Daßler R, Alison MR, Gerdes J. Ki-67 expression during rat liver regeneration after partial hepatectomy. Hepatology 1997; 26: 573-578

37. Glanemann M, Langrehr JM. Klinische Ergebnisse nach orthotoper Lebertransplantation in Abhängigkeit des Ischämie/Reperfusionsschaden. Transplant Linc 2001; 4(2): 58-66

38. Glanemann M, Vollmar B, Nuessler AK, Schaefer T, Neuhaus P, Menger MD. Ischemic preconditioning protects from hepatic ischemia/reperfusion injury by preservation of microcirculation and mitochondrial redox state. J Hepatol 2003; 38: 59-66

39. Glanemann M, Strenziok R, Kuntze R, Münchow S, Dikopoulos N, Lippek F, Langrehr JM, Dietel M, Neuhaus P, Nüssler AK. Ischemic preconnditioning and methylprednisolone both equally reduce hepatic ischemia/reperfusion injury. Surgery 2004; 135: 203-214

40. Granger DN, Korthuis RJ. Physiologic mechanisms of postischemic tissue injury. Annu Rev Physiol 1995; 57: 311-332.

41. Gressner AM. Leber und Gallenwege. In: Greiling H, Gressner AM (Hrsg), Lehrbuch der klinischen Chemie und Pathobiochemie. Schattauer, Stuttgart/New York, 2. Auflage 1989; 421-464

42. Hardy KJ, McClure DN, Subwongcharoen S. Ischaemic preconditioning of the liver: A preliminary study. Aust NZJ Surg 1996; 66: 707-710

43. Hawaleshka A, Jacobsohn E. Ischaemic preconditioning: Mechanisms and potential clinical applications. Can J Anaesth 1998; 45: 670-682

44. Heriot AG, Karanjia ND. A review of techniques for liver resection. Ann R Coll Surg Engl 2002; 84: 371-380

45. Higgins GM, Anderson RM. Experimental pathology of the liver. I. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol 1931; 12: 186-202

46. Hotter G, Closa D, Prados M, Fernandez-Cruz L, Prats N, Gelpi E, Rosello-Catafau J. Intestinal preconditioning is mediated by a transient increase in nitric oxide. Biochem Biophs Res Commun 1996; 222: 27-32

47. Howell JG, Zibari GB, Brown MF, Burney DL, Sawaya DE, Olinde JG, Granger DN, McDonald JC. Both ischemic and pharmacological preconditioning decrease hepatic leukocyte/endothelial cell interactions. Transplantation 2000; 69: 300-303

48. Ishida T, Yarimizu K, Gute DC, Korthuis RJ. Mechanisms of ischemic preconditioning. Shock 1997; 8: 86-94

49. Ishii S, Abe T, Saito T, Tsuchiya T, Kanno H, Miyazawa M, Suzuki M, Motoki R, Gotoh M. Effects of preconditioning on ischemia/reperfusion injury of hepatocytes determined by immediate early gene transcription. J Hepatobiliary Pancreat Surg 2001; 8: 461-468

50. Iu S, Harvey PR, Makowka L, Petrunka CN, Ilson RG, Strasberg SM. Markers of allograft viability in the rat. Relationship between transplantation viability and liver function in the isolated perfused liver. Transplantation 1987; 44: 562-569

51. Jaeschke H, Farhood A. Neutrophil and Kupffer cell-induced oxidant stress and ischemia- reperfusion injury in rat liver Am J Physiol 1991; 260: G355-G362

52. Jaeschke H, Farhood A, Bautista AP, Spolarics Z, Spitzer JJ, Smith CW. Functional inactivation of neutrophils with a Mac-1 (CD11b/CD18) antibody protects against ischemia-reperfusion injury in rat liver. Hepatology 1993; 17: 915-923

53. Jaeschke H. Preservation injury: mechanisms, prevention and consequences. J Hepatol 1996; 25: 774-780

54. Jaeschke H. Cellular adhesion molecules: regulation and functional significance in the pathogenesis of liver diseases. Am J Physiol 1997; 273: G602-G611

55. Jaeschke H, Lemasters JJ. Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology 2003; 125: 1246-1257

56. Kim YI, Salvini P, Auxilia F, Calne RY. Effect of cyclosporine A on hepatocyte proliferation after partial hepatectomy in rats: Comparison with standard immunosuppressive agents. Am J Surgery 1988; 155: 245-249

57. Kim YI. Ischemia-reperfusion injury of the human liver during hepatic resection. J Hepatobiliary Pancreat Surg 2003; 10: 195-199

58. Kita Y, Takashi T, Ligo Y, Tamatani T, Miyasaka M, Horiuchi T. Sequence and expression of rat ICAM-1. Biochem Biophys Acta 1992; 1131: 108-110

59. Kobayashi H, Nonami T, Kurokawa T, Takeuchi Y, Harada A, Nakano A, Takagi H. Role of endogeneous nitric oxide in ischemia-reperfusion injury in rat liver. J Surg Res 1995; 59; 772-779

60. Kountouras J, Boura P, Lygidakis NJ. Liver regeneration after hepatectomy. Hepato-Gastroenterology 2001; 48: 556-562

61. Kooby DA, Stockman J, Ben-Porat L, Gonen M, Jarnagin WR, Dematteo RP, Tuorto S, Wuest D, Blumgart LH, Fong Y. Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg 2003; 237: 860-869

62. Korthuis RJ, Gute DC, Cepinskas G, Kvietys PR. Cellular mechanisms of acute versus delayed preconditioning. Pathophysiology 1998; 5: 35-48

63. Kubes P, Kurose I, Granger DN. NO donors prevent integrin-induced leukocyte adhesion, but not P-selectin dependent rolling in postischemic venules. Am J Physiol 1994; 267: H931-H937

64. Kubes P. The role of adhesion molecules and nitric oxide in intestinal and hepatic ischemia/reperfusion. Hepato-Gastroenterology 1999; 46: 1458-1463

65. Kume M, Yamamoto Y, Saad S. Ischemia preconditioning of the liver in rats: Implications of heat shock protein induction to increase tolerance of ischemia-reperfusion injury. J Lab Clin Med. 1996; 128: 251-258

66. Kuzume M, Nakano H, Yamaguchi M, Matsumiya A, Shimokohbe G, Kitamura N, Nagasaki H, Kumada K. A monoclonal antibody against ICAM-1 suppresses hepatic ischemia-reperfusion injury in rats. Eur Surg Res 1997; 29: 93-100

67. LaBrecque D. Liver regeneration: a picture emerges from the puzzle. Am J Gastroenterol 1994; 89 (Suppl): S86-S96

68. Lemasters JJ, Thurman RG. Reperfusion injury after liver preservation for transplantation. Annu Rev Pharmacol Toxicol 1997; 37: 327-338

69. Lentsch AB, Kato A, Yoshidome H, McMasters KM, Edwards MJ. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology 2000; 32: 169-173

70. Lloris-Carsi JM, Cejalvo D, Toledo-Pereyra LH, Calvo MA, Suzuki S. Preconditioning: effect upon lesion modulation in warm liver ischemia. Transplant Proc 1993; 25: 3303-3304

71. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-275

72. Luss H, DiSilvio M, Litton AL, Molina y Vedia L, Nussler AK, Billiar TR. Inhibition of nitric oxide synthesis enhances the expression of inducible nitric oxide synthase mRNA and protein in a model of chronic liver inflammation. Biochem Biophys Res Commun 1994; 204: 635-640

73. Magnall D, Bird NC, Majeed AW. The molecular physiology of liver regeneration following partial hepatectomy. Liver 2003; 23: 124-138

74. Makuuchi M, Takayama T, Gunven P, Kosige T, Yamazaki S, Hasegawa H. Restrictive versus liberal blood transfusion policy for hepatectomies in cirrhotic patients. World J Surg 1989; 13: 644-648

75. Man DV, Lam WW, Hjelm NM, So NM, Yeung DK, Metreweli C, Lau WY. Human liver regeneration: hepatic energy economy is less efficient when the organ is diseased. Hepatology 2001: 34: 557-565

76. Man K, Lo CM, Ng IO, Wong YC, Qin LF, Fan ST, Wong J. Liver transplantation in rats using small-for-size grafts: a study of hemodynamic and morphological changes. Arch Surg 2001; 136: 280-285

77. Man K, Fan ST, Lo CM, Liu CL, Fung PC, Liang TB, Lee TK, Tsui SH, Ng IO, Zhang ZW, Wong J. Graft injury in relation to graft size in right lobe live donor liver transplantation: a study of hepatic sinusoidal injury in correlation with portal hemodynamics and intragraft gene expression. Ann Surg 2003; 237: 256-264

78. Marcos A, Olzinski AT, Ham JM, et al. The interrelationship between portal and arterial blood flow after adult to adult living donor liver transplantation. Transplantation 2000; 70: 1697-1703

79. Martinez-Mier G, Toledo-Pereyra LH, Ward PA. Adhesion molecules in liver ischemia and reperfusion. Journal of Surgical Research 2000; 94: 185-194

80. McCallion K, Wattanasirichaigoon S, Gardiner KR, Fink MP. Ischemic preconditioning ameliorates ischemia- and reperfusion-induced intestinal epithelial hyperpermeability in rats. Shock. 2000; 14: 429-434

81. Menger MD, Richter S, Yamauchi J, Vollmar B. Role of microcirculation in hepatic ischemia/reperfusion injury. Hepatogastroenterology 1999; 46 (S2): 1452-1457

82. Morita T, Togo S, Kubota T, Kamimukai N, Nishizuka I, Kobayashi M, Ichikawa Y, Ishikawa T, Takahashi S, Matsuo K, Tomaru Y, Okazak Y, Hayashizaki Y, Shimada H. Mechanism of postoperative liver failure after excessive hepatectomy investigated using a cDNA microarray. J Hepatobiliary Pancreat Surg 2002; 9: 352-359

83. Motoyama S, Saito S, Minamiya Y, Saito R, Nakamura M, Okuyama M, Imano H, Ogawa J. Methylprednisolone inhibits low-flow hypoxia-induced mitochondrial dysfunction in isolated perfused rat liver. Crit Care Med 2003; 31: 1468-1474

84. Mueller AR, Platz KP, Haak M, Undi H, Muller C, Kottgen E, Weidemann H, Neuhaus P. The release of cytokines, adhesion molecules, and extracellular matrix parameters during and after reperfusion in human liver transplantation. Transplantation 1996; 62: 1118-1126

85. Muratore A, Ribero D, Ferrero A, Bergero R, Capussotti L. Prospective randomized study of steroids in the prevention of ischaemic injury during hepatic resection with pedicle clamping. Br J Surg 2003; 90: 17-22

86. Murrey CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal injury in ischemic myocardium. Circulation 1986; 74: 1124-1136

87. Nadal C. Dose-related opposite effects of hydrocortisone on hepatocyte proliferation in the rat. Liver 1995; 15: 63-69

88. Nagino M, Kamiya J, Uesaka K, Sano T, Yamamoto H, Hayakawa N, Kanai M, Nimura Y. Complications of hepatectomy for hilar cholangiocarcinoma. World J Surg 2001; 25: 1277-1283

89. Nagy P, Kiss A, Schnur J, Thorgeirsson SS. Dexamethasone inhibits the proliferation of hepatocytes and oval cells but not bile duct cells in rat liver. Hepatology 1998; 28: 423-429

90. Nakayama H, Yamamoto Y, Kume M, Yamagami K, Yamamoto H, Kimoto S, Ishikawa Y, Ozaki N, Shimahara Y, Yamaoka Y. Pharmacologic stimulation of adenosine A2 receptor supplants ischemic preconditioning in providing ischemic tolerance in rat livers. Surgery 1999; 126: 945-954

91. Nilsson B, Friman S, Gustafsson BI, Delbro DS. Preconditioning protects against ischemia/reperfusion injury of the liver. J Gastrointest Surg 2000; 4: 44-49

92. Nudel U, Zakut R, Shani M, Neuman S, Levy Z, Yaffe D. The nucleotide sequence of the rat cytoplasmatic beta-actin gene. Nucleic Acids Res 1983; 11: 1759-1771

93. Nussler AK, Billiar TR. Inflammation, immunoregulation, and inducible nitric oxide synthase. J Leukoc Biol 1993; 54: 171-178

94. Nussler AK, Beger HG, Liu ZZ, Billiar TR. Nitric oxide, hepatocytes and inflammation. Res Immunol 1995; 146: 671-677

95. Ogawa T, Mimura Y, Kanauchi H, Nakamura T, Hiki Y, Kojima J, Kaminishi M. Ischemic preconditioning improves functional damage following prolonged ischemia-reperfusion in the rats kidney. J J Metab Nutri 1998; 72: 117-118

96. Ormrod DJ, Harrison GL, Miller TE. Inhibition of neutrophil myeloperoxidase activity by selected tissues. J Pharmacol Methods 1987; 18: 137-142.

97. Pachter HL, Spencer FC. Recent concepts in the treatment of hepatic trauma. Ann Surg 1979; 190: 423-429

98. Pachter HL, Spencer FC, Hofstetter SR, Liang HG, Coppa GF. Significant trends in the treatment of hepatic trauma. Ann Surg 1991; 215: 492-502

99. Pearl JM, Nelson DP, Schwartz SM, Wagner CJ, Bauer SM, Setser EA, Duffy JY. Glukokorticoids reduce ischemia-reperfusion-induced myocardial apoptosis in immature hearts. Ann Thorac Surg 2002; 74: 830-836

100. Peralta C, Closa D, Hotter G, Gelpi E, Prats N, Rosello-Catafau J. Liver ischemic preconditioning is mediated by the inhibitory action of nitric oxide on endothelin. Biochem Res Commun 1996; 229: 264-269

101. Peralta C, Hotter G, Closa D, Gelpi E, Bulbena O, Rosello-Catafau J. Protective effect of preconditioning on the injury associated to hepatic ischemia-reperfusion in the rat: Role of nitric oxid and adenosine. Hepatology 1997; 25: 934-937

102. Peralta C, Closa D, Xaus C, Gelpi E, Rosello-Catafau J, Hotter G. Hepatic preconditioning in rats is defined by a balance of adenosine and xanthine. Hepatology 1998; 28: 768-773

103. Peralta C, Hotter G, Closa D, Prats N, Xaus C, Gelpi E, Rosello-Catafau J. The protective role of adenosine in inducing nitric oxide synthesis in rat liver ischemia preconditioning is mediated by activation of adenosine A2 receptors. Hepatology 1999; 29: 126-132

104. Peralta C, Bartrons R, Serafin A, Blazquez C, Guzman M, Prats N, Xaus C, Cutillas B, Gelpi E, Rosello-Catafau J. Adenosine monophosphate-activated protein kinase mediates the protective effects of ischemic preconditioning on hepatic ischemia-reperfusion injury in the rat. Hepatology 2001; 34: 1164-1173

105. Peralta C, Bartrons R, Riera L, Manzano A, Xaus C, Gelpi E, Rosello-Catafau J. Hepatic preconditioning preserves energy metabolism during sustained ischemia. Am J Physiol Gastrointest Liver Physiol 2000; 279: G163-G171

106. Peralta C, Fernandez L, Panes J, Prats N, Sans M, Pique JM, Gelpi E, Rosello-Catafau J. Preconditioning protects against systemic disorders associated with hepatic ischemia-reperfusion through blockade of tumor necrosis factor-induced P-selectin up-regulation in the rat. Hepatology 2001; 33: 100-113

107. Pringle JH. Notes on the arrest of hepatic hemorrhage due to trauma. Ann Surg 1908; 48: 541-549

108. Reutzel-Selke A, Zschockelt T, Denecke C, Bachmann U, Jurisch A, Pratschke J, Schmidbauer G, Volk HD, Neuhaus P, Tullius SG. Short-term immunosuppressive treatment of the donor ameliorates consequences of ischemia/ reperfusion injury and long-term graft function in renal allografts from older donors. Transplantation 2003; 75: 1786-1792

109. Richter S, Vollmar B, Mucke I, Post S, Menger MD. Hepatic arteriolo-portal venular shunting guarantees maintenance of nutritional microvascular supply in hepatic arterial buffer response of rat livers. J Physiol 2001; 531: 193-201

110. Rüdiger HA, Kang KJ, Sindram D, Riehle HM, Clavien PA. Comparison of ischemic preconditioning and continuous inflow occlusion in the murine liver. Ann Surg 2002; 235: 400-407

111. Santiago-Delpin EA, Figueroa I, Lopez R, Vazquez J. Protective effect of steroids on liver ischemia. Am Surg 1975; 41: 683-695

112. Sawaya DE Jr, Brown M, Minardi A, Bilton B, Burney D, Granger DN, McDonald JC, Zibari GB. The role of ischemic preconditioning in the recruitment of rolling and adherent leukocytes in hepatic venules after ischemia/reperfusion. J Surg Res 1999; 85: 163-170

113. Scarpulla RC, Agne KM, Wu R. Isolation and structure of a rat cytochrome c gene. J Biol Chem 1981; 256: 6480-6486

114. Schmid RM, Liptay S, Betts JC, Nabel GJ. Structural and functional analysis of NF B. J Biol Chem 1994; 269: 32162-32167

115. Schott RJ, Rohmann S, Braun ER, Schaper W. Ischemic preconditioning reduces infarct size in swine myocardium. Circ Res 1990; 66: 1133-1142

116. Scott RJ, Rohmann S, Braun ER, Schaper W. Ischemic preconditioning reduces infarct size in swine myocardium. Circ Res 1992; 66: 1133-1138

117. Seiler CA, Redaelli C, Schmied BM, Baer HU, Buchler MW. Liver resection for liver metastases-1998 Bern Symposium. Swiss Surg 2000; 6: 164-168

118. Serracino-Inglott F, Habib NA, Mathie RT. Hepatic ischemia-reperfusion injury. Am J Surg 2001; 181: 160-166

119. Shaked A, Nunes FA, Olthoff KM, Lucey MR. Assessment of liver function: pre- and peritransplant evaluation. Clinical Chemistry 1997; 43: 1539-1545

120. Shimada M, Saitoh A, Kano T, Takenaka K, Sugimachi K. The effect of perioperative steroid pulse on surgical stress in hepatic resection. Int Surg 1996; 81: 49-51

121. Steinle AU, Weidenbach H, Wagner M, Adler G, Schmid RM. NF B/Rel activation in cerulein pancreatitis. Gastroenterology 1999; 116: 420-430

122. Strasberg SM, Howard TK, Molmenti EP, Hertl M. Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation. Hepatology 1994; 20: 829-838

123. Streetz KL, Luedde T, Manns MP, Trautwein C. Interleukin 6 and liver regeneration. Gut 2000; 47: 309-312

124. Takahira R, Yonemura K, Fujise Y, Hishida A. Dexamethasone attenuates neutrophil infiltration in the rat kidney in ischemia/reperfusion injury: the possible role of nitroxyl. Free Radic Biol Med 2001; 31: 809-815

125. Takeda K, Togo S, Kunihiro O, Fujii Y, Kurosawa H, Tanaka K, Eno I, Takimoto A, Sekido H, Hara M, Shimada H. Clinicohistological features of liver failure after excessive hepatectomy. Hepatogastroenterology 2002; 49: 354-358

126. Teoh N, Dela Pena A, Farrell G. Hepatic ischemic preconditioning in mice is associated with activation of NF-kappaB, p38 kinase, and cell cycle entry. Hepatology 2002; 36: 94-102

127. Teoh NC, Farrell GC. Hepatic ischemia reperfusion injury: Pathogenic mechanisms and basis for hepatoprotection. J Gastroenterol Hepatol 2003; 18: 891-902

128. Thornton JD, Thornton CS, Sterling DL, Downey JM. Blockade of ATP-sensitive potassium channels increases infarct size but does not prevent preconditioning in rabbit hearts. Circ Res 1993; 72: 44-49

129. Torzilli G, Makuuchi M, Inoue K. The vascular control in liver rsection: revisitation of a controversial issue. Hepatogastroenterology 2002; 49: 28-31

130. Troisi R, de Hemptinne B. Clinical relevance of adapting portal vein flow in living donor liver transplantation in adult patients. Liver Transpl. 2003; 9: S36-41

131. Vajdova K, Heinrich S, Tian Y, Graf R, Clavien PA. Ischemic preconditioning and intermittent clamping improve murine hepatic microcirculation and Kupffer cell function after ischemic injury. Liver Transpl 2004; 10: 520-528

132. Valen G, Kawakami T, Tahepold P et al. Pretreatment with methylprednisolone protects the isolated rat heart against ischemic and oxidative damage. Free Radic Res 2000; 33: 31-43

133. Van Winkle DM, Chien GL, Wolff RA, Doiffer BE, Kuzume K, Davis RF. Cardioprotection provided by adenosine receptor activation is abolished by blockade of the KATP channel. Am J Physiol 1994; 266: H892-H898

134. Vollmar B, Menger MD, Glasz J, Leiderer R, Messmer K. Impact of leukocyte-endothelial cell interaction in hepatic ischemia-reperfusion injury. Am J Physiol 1994; 267: G786-G793

135. Vollmar B, Burkhardt M, Minor T, Klauke H, Menger MD. High-resolution microscopic determination of hepatic NADH fluorescence for in vivo monitoring of tissue oxygenation during hemorrhagic shock and resuscitation. Microvasc Res 1997; 54: 164-73.

136. Wang M, Sakon M, Umeshita K, Okuyama M, Shiozaki K, Nagano H, Dohno K, Nakamori S, Monden M. Prednisolone suppresses ischemia-reperfusion injury of the rat liver by reducing cytokine production and calpain µ activation, J Hepatol 2001; 34: 278-283

137. Wei C, Tung-Ping Poon R, Fan ST, Wong J. Risk factor for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma. Br J Surg 2003; 90: 33-41

138. Yadav SS, Howell DN, Gao W, Steeber DA, Harland RC, Clavien PA. L-selectin and ICAM-1 mediate reperfusion injury and neutrophil adhesion in the warm ischemic mouse liver. Am J Physiol 1997; 275: G1341-G1352

139. Yadav SS, Sindram D, Perry DK, Clavien PA. Ischemic preconditioning protects the mouse liver by inhibition of apoptosis through a caspase-dependent pathway. Hepatology 1999; 30: 1223-1231

140. Yamashita Y, Shimada M, Hamatsu T, Rikimaru T, Tanaka S, Shirabe K, Sugimachi K. Effects of preoperative steroid administration on surgical stress in hepatic resection. Arch Surg 2001; 136: 328-333

141. Yeh KY, Yeh M, Glass J, Granger DN. Rapid activation of NFkB and AP-1 and target gene expression in postischemic intestine. Gastroenterol 2000; 118: 525-534

142. Yellon DM, Alkhulaifi AM, Browne EE, Pugsley WB. Ischaemic preconditioning limmits infarct size in the rat heart. Cardiovasc Res 1992; 26: 983-987

143. Yin DP, Sankary HN, Chong AS, Ma LL, Shen J, Foster P, Williams JW. Protective effect of ischemic preconditioning on liver preservation-reperfusion injury in rats. Transplantation 1998; 66: 152-157

144. Yoshizumi T, Yanaga K, Soejima Y, Maeda T, Uchiyama H, Sugimachi K. Amelioration of liver injury by ischaemic preconditioning. Br J Surg 1998; 85: 1636-1640


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 4.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
19.10.2005